Actively Recruiting
Circulating Markers for Ischemic Heart Disease
Led by UConn Health · Updated on 2025-08-12
550
Participants Needed
1
Research Sites
1030 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.
CONDITIONS
Official Title
Circulating Markers for Ischemic Heart Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women 18 years and older with acute myocardial infarction confirmed by positive cardiac markers (CKMB or troponin) with or without heart failure symptoms
- Heart failure diagnosed by imaging evidence such as dilated heart, poor contractile function, or echocardiographic Doppler evidence of diastolic dysfunction or elevated filling pressures
- Control group of men aged 60 and older without a history of myocardial infarction or heart disease
You will not qualify if you...
- Inability to give consent
- Cardiac or non-cardiac surgery within 3 months prior to enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030
Actively Recruiting
Research Team
F
Fahad Shah
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here